Target intelligence / Profile preview

Engraftment of autologous human keratinocytes and fibroblasts

Molecular classification
Other (cell therapy), Keratinocyte (epithelial cell type), Fibroblast (mesenchymal cell type)
01

Overview

Engraftment of autologous keratinocytes and fibroblasts is a cell-based therapeutic approach in which a patient's own skin cells are cultured and transplanted onto wounds or burns to promote regeneration of healthy, functional skin. Keratinocytes form the epidermal layer and restore the skin barrier, while fibroblasts populate the dermis and secrete extracellular matrix to support tissue structure and healing. The combination accelerates wound closure, improves re-epithelialization, and can reduce scarring by reconstituting both epidermal and dermal architecture through biological interactions that mimic native skin function. This approach does not involve targeting a single molecule or receptor but leverages synergistic effects of combined cell populations to achieve full-thickness skin regeneration.

Other names
Autologous keratinocyte and fibroblast transplantationAutologous skin grafting with keratinocytes and fibroblastsCell-based skin regenerationCultured autologous keratinocytes and fibroblasts engraftment
02

Mechanism of action

Physical engraftment and integration of healthy, autologous skin cells (keratinocytes/fibroblasts) into wound sites. Promotion of wound re-epithelialization and granulation tissue formation. Restoration of skin barrier function via interaction and organization of epidermal and dermal cells. Stimulation of extracellular matrix synthesis and modulation of scar formation by fibroblasts.

03

Biological functions

Skin regenerationWound healingRe-epithelializationExtracellular matrix depositionTissue remodelingCell proliferation
04

Disease associations

BurnsChronic woundsHypertrophic scarsSkin ulcersOther skin injuries/disorders
05

Safety considerations

Risk of infection during cell handling or transplantationGraft failure/rejection (rare with autologous cells, but can occur due to technical failure or poor wound bed)Delayed wound healing, persistent scarring or fibrosisAdverse reactions to supporting scaffolds (e.g., collagen matrices)Potential for tumorigenicity theoretically if cells are extensively cultured, though rare in these protocols
06

Biomarkers

Presence of viable engrafted keratinocytes/fibroblastsImmunostaining for proliferation markers (e.g., Ki67 in keratinocytes)Histological assessment for basement membrane and new epidermis formation

Beyond the preview

Go deeper on Engraftment of autologous human keratinocytes and fibroblasts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Engraftment of autologous human keratinocytes and fibroblasts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call